{"component": "definition", "props": {"groups": [{"samples": [{"hash": "6wy8MuHZv2y", "uri": "/contracts/6wy8MuHZv2y#detail", "label": "Exclusive Commercialization Agreement (Aytu Biopharma, Inc)", "score": 36.7262149213, "published": true}, {"hash": "3pcnvNTHA1O", "uri": "/contracts/3pcnvNTHA1O#detail", "label": "Collaboration and License Agreement (REGENXBIO Inc.)", "score": 36.3593444824, "published": true}, {"hash": "7mJlLFMNyyV", "uri": "/contracts/7mJlLFMNyyV#detail", "label": "Collaboration and License Agreement (Verve Therapeutics, Inc.)", "score": 33.8487319946, "published": true}], "snippet": "means to engage in a Detail.", "size": 71, "snippet_links": [{"key": "engage-in-a", "type": "definition", "offset": [9, 20]}], "hash": "e743e723d1d13de541c304504f9293ae", "id": 1}, {"samples": [{"hash": "leEoYlCMUHL", "uri": "https://aoprals.state.gov/content/documents/DSSRMaster20240716-Interim.docx", "label": "aoprals.state.gov", "score": 19.07670784, "published": false}, {"hash": "hwB39qI2OAS", "uri": "https://aoprals.state.gov/content/documents/July%201,%202024%20DSSRMaster20240701-Interim.docx", "label": "aoprals.state.gov", "score": 19.031873703, "published": false}, {"hash": "2doXtosrFlL", "uri": "https://aoprals.state.gov/Content/Documents/DSSRMaster20221204.docx", "label": "aoprals.state.gov", "score": 17.5854740143, "published": false}], "snippet": "means detail as defined by Section 040p, for a minimum of four (4) cumulative hours in one day, at a place designated a danger pay area . All periods of leave while present at such place of detail may be included to meet the four hour requirement, but days of absence away from the designated post or country/area may not be included. Employees transiting a post who are inadvertently detained thereat for four (4) hours or more shall be considered on detail.", "size": 58, "snippet_links": [{"key": "danger-pay", "type": "clause", "offset": [120, 130]}, {"key": "periods-of-leave", "type": "clause", "offset": [142, 158]}, {"key": "place-of", "type": "definition", "offset": [181, 189]}, {"key": "of-absence", "type": "clause", "offset": [257, 267]}, {"key": "the-designated", "type": "definition", "offset": [278, 292]}, {"key": "hours-or-more", "type": "clause", "offset": [415, 428]}], "hash": "b3cc127437932d5765e9cddcc95fc63a", "id": 2}, {"samples": [{"hash": "leEoYlCMUHL", "uri": "https://aoprals.state.gov/content/documents/DSSRMaster20240716-Interim.docx", "label": "aoprals.state.gov", "score": 19.07670784, "published": false}, {"hash": "ckFmegqhgN8", "uri": "https://aoprals.state.gov/content/documents/500%20POST%20HARDSHIP%20DIFFERENTIAL%2020240308.docx", "label": "aoprals.state.gov", "score": 19.0331726074, "published": false}, {"hash": "hwB39qI2OAS", "uri": "https://aoprals.state.gov/content/documents/July%201,%202024%20DSSRMaster20240701-Interim.docx", "label": "aoprals.state.gov", "score": 19.031873703, "published": false}], "snippet": "means detail as defined in Section 040p for a minimum of 24 consecutive hours, counted from the time of arrival at a place other than the employee\u2019s post (Section 040h) including also all periods of leave while serving at the place of detail.", "size": 53, "snippet_links": [{"key": "defined-in-section", "type": "clause", "offset": [16, 34]}, {"key": "consecutive-hours", "type": "clause", "offset": [60, 77]}, {"key": "time-of-arrival", "type": "clause", "offset": [96, 111]}, {"key": "the-employee", "type": "clause", "offset": [134, 146]}, {"key": "periods-of-leave", "type": "clause", "offset": [188, 204]}, {"key": "place-of", "type": "definition", "offset": [226, 234]}], "hash": "1082c069b032523a6c42b1384956ea06", "id": 3}, {"samples": [{"hash": "2doXtosrFlL", "uri": "https://aoprals.state.gov/Content/Documents/DSSRMaster20221204.docx", "label": "aoprals.state.gov", "score": 17.5854740143, "published": false}, {"hash": "6cnwg1R9lTZ", "uri": "https://aoprals.state.gov/content/Documents/DSSRMaster20210103.doc", "label": "aoprals.state.gov", "score": 11.940451622, "published": false}, {"hash": "lahrTgREWhv", "uri": "https://aoprals.state.gov/Content/Documents/DSSRMaster20230827%20-%20Final%20Form.docx", "label": "aoprals.state.gov", "score": 11.821354866, "published": false}], "snippet": "means the temporary assignment or temporary duty (including temporary duty for consultation) of an employee away from his/her post (Section 040h). (See also Section 511c with respect to post hardship differential, Section 651c concerning danger pay, and Section 811c concerning compensatory time off.) (eff. 5/1/05 TL:SR 650)", "size": 50, "snippet_links": [{"key": "temporary-duty", "type": "definition", "offset": [34, 48]}, {"key": "an-employee", "type": "definition", "offset": [96, 107]}, {"key": "with-respect-to", "type": "clause", "offset": [170, 185]}, {"key": "post-hardship-differential", "type": "definition", "offset": [186, 212]}, {"key": "danger-pay", "type": "clause", "offset": [238, 248]}, {"key": "compensatory-time-off", "type": "definition", "offset": [278, 299]}], "hash": "70a974a16ec100c1dad9f231f232ad63", "id": 4}, {"samples": [{"hash": "SDmewiYpL5", "uri": "/contracts/SDmewiYpL5#detail", "label": "Co Development and License Agreement (Innate Pharma SA)", "score": 30.716632843, "published": true}, {"hash": "l4XpingNeaf", "uri": "/contracts/l4XpingNeaf#detail", "label": "Collaboration and License Agreement (Xencor Inc)", "score": 30.3497600555, "published": true}, {"hash": "gNgJXBZp4Lr", "uri": "/contracts/gNgJXBZp4Lr#detail", "label": "Collaboration and License Agreement (Lexicon Pharmaceuticals, Inc.)", "score": 27.4503765106, "published": true}], "snippet": "or \u201cDetailing\u201d means to perform a Detail.", "size": 34, "snippet_links": [], "hash": "73bf1b2318d6dc7d414a46adc61a6428", "id": 5}, {"samples": [{"hash": "6N28zVXt1rN", "uri": "https://www.mcieast.marines.mil/Portals/33/Documents/Brig/Manual%20Court%20Martial%20(MCM)%20%20(2023%20Edition).pdf?ver=pECkw6O3nIfQNYsmCAwIKg%3D%3D", "label": "www.mcieast.marines.mil", "score": 16.2211112976, "published": false}, {"hash": "1LKyq3LtioW", "uri": "https://jsc.defense.gov/Portals/99/2023%20MCM%20(w_%20preface)%20(2023_09_15).pdf?ver=DYv_dgnVlSTjgwUwpO2piQ%3D%3D", "label": "jsc.defense.gov", "score": 11.826830864, "published": false}, {"hash": "4odJGXbDQIu", "uri": "https://public-inspection.federalregister.gov/2018-04860.pdf?1520439320", "label": "Executive Order", "score": 11.0889797211, "published": false}], "snippet": "means to order a person to perform a specific temporary duty, unless the context indicates otherwise.", "size": 30, "snippet_links": [{"key": "a-person", "type": "clause", "offset": [15, 23]}, {"key": "temporary-duty", "type": "definition", "offset": [46, 60]}, {"key": "the-context", "type": "clause", "offset": [69, 80]}], "hash": "cfee69493994bb4a0d05b2cd6e5cd2ff", "id": 6}, {"samples": [{"hash": "7WVm0PQH8UG", "uri": "https://www.govinfo.gov/content/pkg/USCODE-2006-title5/pdf/USCODE-2006-title5-partIII-subpartB-chap33.pdf", "label": "www.govinfo.gov", "score": 13.8334941864, "published": false}, {"hash": "72f6d8jTzwi", "uri": "https://www.govinfo.gov/content/pkg/USCODE-1995-title5/pdf/USCODE-1995-title5-partIII-subpartB-chap33.pdf", "label": "www.govinfo.gov", "score": 9.9514036179, "published": false}, {"hash": "1uCgrs2UUa1", "uri": "https://www.govinfo.gov/content/pkg/USCODE-2014-title5/pdf/USCODE-2014-title5-partIII.pdf", "label": "www.govinfo.gov", "score": 9.8542098999, "published": false}], "snippet": "\u2019 means the assignment or loan of an employee to an international organization without a change of position from the agency by which he is employed to an international organization.", "size": 17, "snippet_links": [{"key": "assignment-or", "type": "clause", "offset": [12, 25]}, {"key": "an-employee", "type": "definition", "offset": [34, 45]}, {"key": "international-organization", "type": "clause", "offset": [52, 78]}, {"key": "change-of-position", "type": "clause", "offset": [89, 107]}, {"key": "the-agency", "type": "clause", "offset": [113, 123]}], "hash": "4ed5064dcb41d66acd4be3c228a30516", "id": 7}, {"samples": [{"hash": "gkudUX2KX9L", "uri": "/contracts/gkudUX2KX9L#detail", "label": "Commercialization Agreement (Salix Pharmaceuticals LTD)", "score": 25.5995883942, "published": true}, {"hash": "aHKZHEL8lK8", "uri": "/contracts/aHKZHEL8lK8#detail", "label": "Commercialization Agreement (Depomed Inc)", "score": 22.8480491638, "published": true}, {"hash": "3BDb4SNQJSG", "uri": "/contracts/3BDb4SNQJSG#detail", "label": "Commercialization Agreement (Santarus Inc)", "score": 22.8480491638, "published": true}], "snippet": "means an in-person, face-to-face sales presentation of a Product made by a Sales Representative to a Professional, including a P1 Detail or P2 Detail.", "size": 16, "snippet_links": [{"key": "sales-presentation", "type": "definition", "offset": [33, 51]}, {"key": "sales-representative", "type": "clause", "offset": [75, 95]}, {"key": "a-professional", "type": "clause", "offset": [99, 113]}, {"key": "p1-detail", "type": "definition", "offset": [127, 136]}, {"key": "p2-detail", "type": "definition", "offset": [140, 149]}], "hash": "ff2c153d6a306c35370e113d13b96055", "id": 8}, {"samples": [{"hash": "cBlQ6dTV8Mr", "uri": "/contracts/cBlQ6dTV8Mr#detail", "label": "Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "mNHm0OY40j", "uri": "/contracts/mNHm0OY40j#detail", "label": "Collaboration Agreement (Discovery Partners International Inc)", "score": 21.0, "published": true}, {"hash": "i3bRX4mtKZe", "uri": "/contracts/i3bRX4mtKZe#detail", "label": "Collaboration Agreement (Infinity Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "snippet": "means mean face-to-face discussions with physicians and other health care practitioners who are permitted under applicable Laws to prescribe a Licensed Product for the purpose of promoting a Licensed Product to such physicians or practitioners.", "size": 14, "snippet_links": [{"key": "health-care", "type": "definition", "offset": [62, 73]}, {"key": "applicable-laws", "type": "definition", "offset": [112, 127]}, {"key": "licensed-product", "type": "clause", "offset": [143, 159]}, {"key": "for-the-purpose-of", "type": "definition", "offset": [160, 178]}], "hash": "bd0e56a6bc9b15947117c58784e89edb", "id": 9}, {"samples": [{"hash": "iqRXESKPUEC", "uri": "/contracts/iqRXESKPUEC#detail", "label": "Product Commercialization Agreement (Iterum Therapeutics PLC)", "score": 36.5920600891, "published": true}, {"hash": "k9IvftCmF3I", "uri": "/contracts/k9IvftCmF3I#detail", "label": "Commercial Services Agreement (Evoke Pharma Inc)", "score": 30.3600273132, "published": true}, {"hash": "4W54AIXCxPr", "uri": "/contracts/4W54AIXCxPr#detail", "label": "Commercial Services Agreement (Evoke Pharma Inc)", "score": 30.3470230103, "published": true}], "snippet": "means to perform a Detail.", "size": 13, "snippet_links": [], "hash": "f3399007b3f6641d869698cc0497890f", "id": 10}], "next_curs": "ClMSTWoVc35sYXdpbnNpZGVyY29udHJhY3Rzci8LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIPZGV0YWlsIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Detail", "snippet": "means to engage in a Detail.", "size": 858, "id": "detail", "examples": ["On a country-by-country basis, the JCC may determine the position in which the Licensed Product shall be Detailed (e.g., Primary Position <strong>Detail</strong> or other position), including the portion of <strong>Details</strong> that must satisfy such positioning requirements and the time periods for which such requirements shall apply, and all such Detailing requirements, if any, for the applicable Licensed Product in the applicable country shall be set forth in the Co-Commercialization Plan."], "related": [["particulars", "Particulars", "Particulars"], ["details", "Details", "<strong>Details</strong>"], ["explanation", "Explanation", "Explanation"], ["reasonable", "Reasonable", "Reasonable"], ["detailing", "Detailing", "Detailing"]], "related_snippets": [], "updated": "2025-09-25T05:32:03+00:00"}, "json": true, "cursor": ""}}